1017 related articles for article (PubMed ID: 26156022)
1. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
[TBL] [Abstract][Full Text] [Related]
2. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
[TBL] [Abstract][Full Text] [Related]
3. Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data.
Santa Cruz O; Tsoutsou P; Castella C; Khanfir K; Anchisi S; Bouayed S; Matzinger O; Ozsahin M
Oncology; 2018; 95(2):61-68. PubMed ID: 29895020
[TBL] [Abstract][Full Text] [Related]
4. Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis.
Roeder F; Ulrich A; Habl G; Uhl M; Saleh-Ebrahimi L; Huber PE; Schulz-Ertner D; Nikoghosyan AV; Alldinger I; Krempien R; Mechtersheimer G; Hensley FW; Debus J; Bischof M
BMC Cancer; 2014 Aug; 14():617. PubMed ID: 25163595
[TBL] [Abstract][Full Text] [Related]
5. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
[TBL] [Abstract][Full Text] [Related]
6. The role of surgery and radiotherapy in treatment of soft tissue sarcomas of the head and neck region: review of 30 cases.
Fayda M; Aksu G; Yaman Agaoglu F; Karadeniz A; Darendeliler E; Altun M; Hafiz G
J Craniomaxillofac Surg; 2009 Jan; 37(1):42-8. PubMed ID: 18804382
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure after postoperative intensity-modulated radiotherapy for locally advanced and recurrent head and neck cancer.
Ooishi M; Motegi A; Kawashima M; Arahira S; Zenda S; Nakamura N; Ariji T; Tokumaru S; Sakuraba M; Tahara M; Hayashi R; Akimoto T
Jpn J Clin Oncol; 2016 Oct; 46(10):919-927. PubMed ID: 27511989
[TBL] [Abstract][Full Text] [Related]
8. Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity.
Alektiar KM; Brennan MF; Healey JH; Singer S
J Clin Oncol; 2008 Jul; 26(20):3440-4. PubMed ID: 18612160
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
[TBL] [Abstract][Full Text] [Related]
10. [Soft tissue sarcoma of the head and neck area in adults. Outcome of combined surgery and irradiation and radiotherapy alone].
Willers H; Hug EB; Spiro IJ; Efird JT; Rosenberg AE; Wang CC
Strahlenther Onkol; 1997 Mar; 173(3):131-5. PubMed ID: 9122852
[TBL] [Abstract][Full Text] [Related]
11. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for Adult Soft Tissue Sarcomas of the Head and Neck.
O'steen L; Saldivar B; Kharod S; Bassett B; Morris CG; Mendenhall WM
Am J Clin Oncol; 2020 Sep; 43(9):667-669. PubMed ID: 32889838
[TBL] [Abstract][Full Text] [Related]
13. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
14. Multimodality local therapy for retroperitoneal sarcoma.
Paryani NN; Zlotecki RA; Swanson EL; Morris CG; Grobmyer SR; Hochwald SN; Marcus RB; Indelicato DJ
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1128-34. PubMed ID: 21664065
[TBL] [Abstract][Full Text] [Related]
15. Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.
Wang D; Zhang Q; Eisenberg BL; Kane JM; Li XA; Lucas D; Petersen IA; DeLaney TF; Freeman CR; Finkelstein SE; Hitchcock YJ; Bedi M; Singh AK; Dundas G; Kirsch DG
J Clin Oncol; 2015 Jul; 33(20):2231-8. PubMed ID: 25667281
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
17. Dose intensified hypofractionated intensity-modulated radiotherapy with synchronous cetuximab for intermediate stage head and neck squamous cell carcinoma.
Thomson DJ; Ho KF; Ashcroft L; Denton K; Betts G; Mais KL; Garcez K; Yap BK; Lee LW; Sykes AJ; Rowbottom CG; Slevin NJ
Acta Oncol; 2015 Jan; 54(1):88-98. PubMed ID: 25279959
[TBL] [Abstract][Full Text] [Related]
18. Adult head and neck soft tissue sarcomas.
Chen SA; Morris CG; Amdur RJ; Werning JW; Villaret DB; Mendenhall WM
Am J Clin Oncol; 2005 Jun; 28(3):259-63. PubMed ID: 15923798
[TBL] [Abstract][Full Text] [Related]
19. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
20. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
